Figs Inc vs Manhattan Associates Inc — how do they compare? Figs Inc trades at $10.17 (market cap $1.66B), while Manhattan Associates Inc trades at $156.66 (market cap $9.26B). The key difference: Manhattan Associates Inc is far larger — about 5.6× Figs Inc's market cap. Which is the better fit depends on your goals.
| FIGS | MANH | |
|---|---|---|
Market Cap | $1.66B | $9.26B |
Sector | Consumer Cyclical | Technology |
52-Week High | $17.12 | $227.94 |
52-Week Low | $5.81 | $120.88 |
Enterprise Value | $1.44B | $9.09B |
Signals from Pluang's Aura AI — not financial advice
FIGS trades at $9.72, down 2.8% today, amid bearish technical signals despite recent earnings beats. Revenue grew to $631M in 2025 with a 66.6% gross margin, but net cash flow remains negative. Analyst consensus is bullish with a $19.50 price target, though technical indicators show selling pressure with RSI at neutral levels and ADX signaling a strong downtrend.
The stock presents a growth opportunity with strong fundamentals and analyst support, but faces near-term technical headwinds and margin pressures from tariffs and freight costs. Investors should weigh the 100% upside to consensus target against execution risks and persistent negative cash flow trends.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →